Pacific Bio CA Rg
PACB
USD
STOCK MARKET:
NMS
Closed
 
...
Large gap with delayed quotes
Last quote
02/28/2026 - 02:00:00
Bid
02/27/2026 - 21:59:59
Bid
Volume
Ask
02/27/2026 - 21:59:59
Ask
Volume
1.68
-0.10 ( -5.62% )
1.68
24,800
1.69
54,500
More information
Analysis by TheScreener
24.02.2026
Evaluation Slightly negative  
Interest None  
Sensibility High  
Analysis date: 24.02.2026
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 24.02.2026.
Interest
  None
No stars since 06.02.2026.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 02.12.2025 at a price of 2.32.
Evaluation
  Strongly overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
  Negative
 
The dividend-adjusted forty day technical trend is negative since 03.02.2026.
4wk Rel Perf
  -35.29%
 
The four-week dividend-adjusted underperformance versus SP500 is 35.29%.
Sensibility
  High
High, no change over 1 year.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 6.29%.
Mkt Cap in $bn
  0.50
With a market capitalization <$2bn, PACIFIC BSCS.OF CAL. is considered a small-cap stock.
G/PE Ratio
  3.16
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
  -3.88
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
  12.25%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
  7
Over the last seven weeks, an average of 7 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  85
For 1% of index variation, the stock varies on average by 0.85%.
Correlation
  0.17
Stock movements are totally independent of index variations.
Value at Risk
  0.88
The value at risk is estimated at USD 0.88. The risk is therefore 53.31%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  29.04.2011